|
|
 A former senior consultant at Milestone, Dr. Wilson continues her consulting career as VP and Chief Scientific Officer at Aclairo®. Prior to consulting, Dr. Wilson was a pharmacology/toxicology reviewer in the Division of Anti-inflammatory, Analgesic, and Ophthalmic Drug Products and the Division of Medical Imaging and Radiopharmaceutical Drug Products. While at the FDA, she served as co-chair of the Immunotoxicology Working Group, provided consultation to the review divisions at FDA on issues of immunotoxicology, and served on the InterAgency Coordinating Committee for the Validation of Alternative Methods subcommittees for Immunotoxicology and Ophthalmic Drugs. In addition, Dr. Wilson has approximately 10 years of veterinary medicine practice experience. As a consultant, Dr. Wilson has developed toxicology plans, provided regulatory strategies to facilitate drug development, prepared regulatory submissions, participated in FDA meetings, conducted due diligence, and participated on several expert panels. Her areas of expertise include immunotoxicology and issues related to endocrine, anti-inflammatory and ophthalmic drug products, large molecular weight products, as well as imaging agents. |
|
|
